Best Stocks Under $50 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $50.00 (50 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Glencore OTCMKTS:GLNCY$8.25 +0.05 (+0.61%) As of 02/20/2025 03:59 PM EasternGlencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about GlencoreMarket Capitalization$50.02 billionConsensus RatingStrong BuyVolume1.82 million sharesAverage Volume895,873 sharesToday's Range$8.13▼$8.3150-Day Range$8.20▼$9.38 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Green Thumb Industries OTCMKTS:GTBIF$6.99 +0.00 (+0.04%) As of 02/20/2025 03:59 PM EasternGreen Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. More about Green Thumb IndustriesMarket Capitalization$1.48 billionP/E Ratio29.14Consensus RatingStrong BuyConsensus Price Target$16.50 (+136.0% Upside)Volume495,227 sharesAverage Volume499,337 shares3. Serve Robotics NASDAQ:SERV$13.10 -0.26 (-1.95%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$13.18 +0.08 (+0.58%) As of 07:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Serve Robotics Inc designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. More about Serve RoboticsMarket Capitalization$592.04 millionConsensus RatingStrong BuyConsensus Price Target$19.50 (+48.9% Upside)Volume8.83 million sharesAverage Volume12.66 million sharesToday's Range$12.66▼$13.474. Denison Mines NYSEAMERICAN:DNN$1.58 -0.02 (-1.25%) Closing price 02/20/2025 04:10 PM EasternExtended Trading$1.60 +0.01 (+0.95%) As of 07:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MinesMarket Capitalization$1.43 billionConsensus RatingStrong BuyConsensus Price Target$3.00 (+89.9% Upside)Volume53.01 million sharesAverage Volume45.35 million sharesToday's Range$1.58▼$1.645. J Sainsbury OTCMKTS:JSAIY$12.60 +0.01 (+0.08%) As of 02/20/2025 03:50 PM EasternJ Sainsbury plc, together with its subsidiaries, engages in the food, general merchandise and clothing retailing, and financial services activities in the United Kingdom and the Republic of Ireland. More about J SainsburyMarket Capitalization$7.36 billionConsensus RatingStrong BuyVolume20,341 sharesAverage Volume33,699 sharesToday's Range$12.44▼$12.6450-Day Range$12.59▼$14.346. Mereo BioPharma Group NASDAQ:MREO$2.87 -0.04 (-1.37%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$3.05 +0.18 (+6.31%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma GroupMarket Capitalization$451.47 millionConsensus RatingBuyConsensus Price Target$7.83 (+172.9% Upside)Volume425,743 sharesAverage Volume895,993 sharesToday's Range$2.85▼$2.927. OnKure Therapeutics NASDAQ:OKUR$5.46 -0.24 (-4.21%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$5.50 +0.04 (+0.64%) As of 02/20/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure TherapeuticsMarket Capitalization$19.05 millionP/E Ratio-0.45Consensus RatingBuyConsensus Price Target$36.00 (+559.3% Upside)Volume29,463 sharesAverage Volume77,538 shares8. Franklin BSP Realty Trust NYSE:FBRT$13.18 -0.04 (-0.26%) Closing price 02/20/2025 03:59 PM EasternExtended Trading$13.18 +0.00 (+0.04%) As of 02/20/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Benefit Street Partners operates as a self-managed real estate investment trust (REIT). BSP earns income from investing in a leveraged portfolio of residential mortgage pass-through securities consisting almost exclusively of adjustable-rate mortgage (ARM) securities issued and guaranteed by government-sponsored enterprises, either Federal National Mortgage Association (Fannie Mae) or Federal Home Loan Mortgage Corporation (Freddie Mac) (together, the government-sponsored enterprises (GSEs)), or by an agency of the federal government, Government National Mortgage Association (Ginnie Mae). More about Franklin BSP Realty TrustMarket Capitalization$1.08 billionP/E Ratio15.87Consensus RatingBuyConsensus Price Target$15.63 (+18.6% Upside)Volume403,902 sharesAverage Volume357,692 shares9. Mirion Technologies NYSE:MIR$16.68 -0.25 (-1.49%) Closing price 02/20/2025 03:59 PM EasternExtended Trading$16.39 -0.29 (-1.72%) As of 07:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. More about Mirion TechnologiesMarket Capitalization$3.93 billionConsensus RatingBuyConsensus Price Target$19.25 (+15.4% Upside)Volume1.94 million sharesAverage Volume2.32 million sharesToday's Range$16.37▼$17.0810. Aviva OTCMKTS:AVVIY$12.75 +0.07 (+0.55%) As of 02/20/2025 03:50 PM EasternAviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. More about AvivaMarket Capitalization$16.97 billionConsensus RatingBuyVolume8,370 sharesAverage Volume21,711 sharesToday's Range$12.66▼$12.7550-Day Range$11.59▼$12.9811. Hudbay Minerals NYSE:HBM$7.60 -0.14 (-1.74%) Closing price 02/20/2025 03:59 PM EasternExtended Trading$7.66 +0.05 (+0.67%) As of 07:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hudbay Minerals Inc, a diversified mining company, focuses on the exploration, development, operation, and optimization of properties in North and South America. More about Hudbay MineralsMarket Capitalization$3.06 billionP/E Ratio42.25Consensus RatingBuyConsensus Price Target$11.17 (+46.8% Upside)Volume5.49 million sharesAverage Volume7.23 million shares12. Cidara Therapeutics NASDAQ:CDTX$22.38 -1.43 (-6.01%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$22.12 -0.27 (-1.18%) As of 07:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cidara Therapeutics, Inc, a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. More about Cidara TherapeuticsMarket Capitalization$167.78 millionConsensus RatingBuyConsensus Price Target$32.20 (+43.9% Upside)Volume84,259 sharesAverage Volume91,706 sharesToday's Range$20.50▼$23.4013. Bioceres Crop Solutions NASDAQ:BIOX$4.74 +0.03 (+0.64%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$4.79 +0.05 (+1.05%) As of 02/20/2025 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop SolutionsMarket Capitalization$295.37 millionP/E Ratio237.12Consensus RatingBuyConsensus Price Target$9.88 (+108.3% Upside)Volume256,828 sharesAverage Volume334,679 shares14. enCore Energy NASDAQ:EU$2.74 -0.01 (-0.36%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$2.76 +0.02 (+0.73%) As of 02/20/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$511.82 millionConsensus RatingBuyConsensus Price Target$6.50 (+137.2% Upside)Volume846,374 sharesAverage Volume1.51 million sharesToday's Range$2.73▼$2.8315. Achieve Life Sciences NASDAQ:ACHV$3.22 +0.01 (+0.31%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$3.22 0.00 (0.00%) As of 02/20/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life SciencesMarket Capitalization$110.39 millionConsensus RatingBuyConsensus Price Target$14.80 (+359.6% Upside)Volume104,241 sharesAverage Volume244,527 sharesToday's Range$3.20▼$3.2616. Quince Therapeutics NASDAQ:QNCX$1.45 +0.02 (+1.40%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$1.45 0.00 (0.00%) As of 07:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$62.92 millionConsensus RatingBuyConsensus Price Target$9.50 (+555.2% Upside)Volume78,986 sharesAverage Volume107,919 sharesToday's Range$1.40▼$1.4717. Solid Biosciences NASDAQ:SLDB$6.00 -0.47 (-7.26%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$6.10 +0.10 (+1.67%) As of 07:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid BiosciencesMarket Capitalization$262.55 millionConsensus RatingBuyConsensus Price Target$15.40 (+156.7% Upside)Volume4.41 million sharesAverage Volume5.06 million sharesToday's Range$5.65▼$6.5018. ARS Pharmaceuticals NASDAQ:SPRY$11.78 -0.22 (-1.83%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$12.22 +0.44 (+3.74%) As of 07:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ARS Pharmaceuticals, Inc, a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. More about ARS PharmaceuticalsMarket Capitalization$1.17 billionConsensus RatingBuyConsensus Price Target$28.80 (+144.5% Upside)Volume838,805 sharesAverage Volume1.17 million sharesToday's Range$11.73▼$12.1519. Aura Biosciences NASDAQ:AURA$7.63 -0.02 (-0.26%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$7.63 0.00 (0.00%) As of 02/20/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aura Biosciences, Inc, a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. More about Aura BiosciencesMarket Capitalization$382.13 millionConsensus RatingBuyConsensus Price Target$23.00 (+201.4% Upside)Volume128,348 sharesAverage Volume135,679 sharesToday's Range$7.55▼$7.7220. Cardiol Therapeutics NASDAQ:CRDL$1.30 +0.08 (+6.56%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$1.30 0.00 (0.00%) As of 02/20/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol TherapeuticsMarket Capitalization$100.78 millionConsensus RatingBuyConsensus Price Target$8.40 (+546.2% Upside)Volume345,578 sharesAverage Volume254,283 sharesToday's Range$1.19▼$1.3221. Aclaris Therapeutics NASDAQ:ACRS$2.31 0.00 (0.00%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$2.32 +0.00 (+0.22%) As of 02/20/2025 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$165.00 millionP/E Ratio-4.44Consensus RatingBuyConsensus Price Target$11.00 (+376.2% Upside)Volume354,822 sharesAverage Volume805,373 shares22. Nkarta NASDAQ:NKTX$2.15 -0.14 (-6.11%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$2.17 +0.02 (+0.88%) As of 07:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$161.60 millionConsensus RatingBuyConsensus Price Target$15.00 (+597.7% Upside)Volume874,766 sharesAverage Volume797,249 sharesToday's Range$2.12▼$2.2923. GeoVax Labs NASDAQ:GOVX$1.63 -0.08 (-4.68%) As of 02/20/2025 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$16.14 millionConsensus RatingBuyConsensus Price Target$14.20 (+771.2% Upside)Volume361,477 sharesAverage Volume523,802 sharesToday's Range$1.62▼$1.7224. Reviva Pharmaceuticals NASDAQ:RVPH$1.63 -0.05 (-2.98%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$1.64 +0.02 (+0.92%) As of 07:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$56.18 millionConsensus RatingBuyConsensus Price Target$11.40 (+599.4% Upside)Volume1.32 million sharesAverage Volume1.35 million sharesToday's Range$1.58▼$1.7025. Rezolve AI NASDAQ:RZLV$2.58 -0.06 (-2.27%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$2.63 +0.05 (+1.94%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AIMarket Capitalization$444.22 millionConsensus RatingBuyConsensus Price Target$6.40 (+148.1% Upside)Volume3.77 million sharesAverage Volume8.18 million sharesToday's Range$2.48▼$2.67 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive SoundHound AI Stock at a Crossroads—Is a Bottom in Sight? SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It? Buffett’s Billion-Dollar Bet: Will Constellation Brands Pay Off? 3 Stocks With Robust Growth Outlooks Insiders Are Buying Buffett Just Dumped His S&P 500 Holdings—What It Means for You Up Nearly 1000%, Can AppLovin Keep Delivering for Investors? Hims & Hers Earnings Could Be a Game Changer—What to Do Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
